Aurobindo Pharma gets USFDA nod for its expectorant tablets

The company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin extended-release tablets in the strengths of 600 mg and 1,200 mg.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BF6sWv
via IFTTT